Metachronous breast cancer and possibilities of prognosis

The RSO and RSMC Samarkand included 68 patients with metacarpenic breast cancer from 2007 to 2017. More than half of the patients were women of reproductive age (26-49 years). The difference between the primary and metacarpal cancer in unilateral cancer was detected at a very early stage of the disease. This is because patients with cancer treatment are in deep dosing. Metaxron is one of the major factors affecting the survival of patients with ovarian cancer: the second stage of cancer, the size of the tumor in the lactation, the volume of treatment, the rate of damage to the regional lymph nodes and the patient's age